Skip to main content
. 2020 Nov 22;2020:8874424. doi: 10.1155/2020/8874424

Figure 1.

Figure 1

Comparison of pretests-posttests of cognitive rehabilitation, control, donepezil and placebo on memory performance, attention, quality of life, and depression in multiple sclerosis patients. CR: cognitive rehabilitation; ns: not significant. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.0001.